Mason Street Advisors’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-37,546
Closed -$3.78M 1896
2014
Q4
$3.78M Sell
37,546
-256
-0.7% -$19.9K 0.03% 673
2014
Q3
$2.51M Buy
37,802
+474
+1% +$31.1K 0.02% 829
2014
Q2
$2.61M Buy
37,328
+88
+0.2% +$5.99K 0.02% 826
2014
Q1
$2.72M Buy
37,240
+218
+0.6% +$16.3K 0.02% 805
2013
Q4
$2.55M Sell
37,022
-82,408
-69% -$5.33M 0.02% 812
2013
Q3
$7.59M Sell
119,430
-380
-0.3% -$23K 0.09% 264
2013
Q2
$5.79M Buy
+119,810
New +$5.89M 0.06% 342

Mason Street Advisors's CBST Position: Q1 2015 in Review

Mason Street Advisors sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 37,546 shares — an estimated $3.78M sold.

Mason Street Advisors first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $7.59M in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Mason Street Advisors reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Mason Street Advisors sold 37,546 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $3.78M.
  • Mason Street Advisors first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Mason Street Advisors's CUBIST PHARMACEUTICALS INC position peaked at $7.59M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.